ACM
Atika Capital Management Portfolio holdings
AUM
$957M
1-Year Return
61.67%
This Quarter Return
+12.56%
1 Year Return
+61.67%
3 Year Return
+345.35%
5 Year Return
+907.8%
10 Year Return
+13,504.21%
AUM
$224M
AUM Growth
+$34.2M
(+18%)
Cap. Flow
+$19.7M
Cap. Flow
% of AUM
8.77%
Top 10 Holdings %
Top 10 Hldgs %
36.35%
Holding
87
New
23
Increased
14
Reduced
26
Closed
16
Top Buys
| 1 |
American Airlines Group
AAL
|
$6.09M |
| 2 |
Align Technology
ALGN
|
$5.85M |
| 3 |
Take-Two Interactive
TTWO
|
$5.5M |
| 4 |
Liberty Media Series C
FWONK
|
$4.72M |
| 5 |
Intuitive Surgical
ISRG
|
$4.49M |
Top Sells
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$6.3M |
| 2 |
Incyte
INCY
|
$4.81M |
| 3 |
AGN
Allergan plc
AGN
|
$4.66M |
| 4 |
United Airlines
UAL
|
$2.93M |
| 5 |
Nexstar Media Group
NXST
|
$2.91M |
Sector Composition
| 1 | Healthcare | 36.05% |
| 2 | Technology | 20.73% |
| 3 | Communication Services | 17.53% |
| 4 | Consumer Discretionary | 7.5% |
| 5 | Materials | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cognex
CGNX
$7.39B
| $1.7M | 0.59% |
+40,000
| New | +$1.7M |
|
|
SIOX
52
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.62M | 0.57% |
8,750
+6,000
| +218% | +$1.11M |
|
|
NDRM
53
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $1.62M | 0.57% |
+54,000
| New | +$1.62M |
|
54
Exelixis
EXEL
$10B
| $1.6M | 0.56% |
65,000
-10,000
| -13% | -$246K |
|
55
EPAM Systems
EPAM
$9.41B
| $1.6M | 0.56% |
19,000
-13,000
| -41% | -$1.09M |
|
|
OTIC
56
DELISTED
Otonomy, Inc.
OTIC
| $1.58M | 0.55% |
+84,000
| New | +$1.58M |
|
57
Galapagos
GLPG
$2.04B
| $1.38M | 0.48% |
18,000
-7,800
| -30% | -$597K |
|
58
Alkermes
ALKS
$4.78B
| $1.22M | 0.43% |
21,000
-1,000
| -5% | -$58K |
|
|
GIMO
59
DELISTED
Gigamon Inc.
GIMO
| $1.18M | 0.41% |
+30,000
| New | +$1.18M |
|
|
DOOR
60
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.13M | 0.4% |
15,000
-29,400
| -66% | -$2.22M |
|
61
Heron Therapeutics
HRTX
$196M
| $1.08M | 0.38% |
78,000
-17,000
| -18% | -$235K |
|
62
Glaukos
GKOS
$5.23B
| $746K | 0.26% |
18,000
-70,000
| -80% | -$2.9M |
|
|
SAGE
63
DELISTED
Sage Therapeutics
SAGE
| $557K | 0.2% |
7,000
-2,000
| -22% | -$159K |
|
|
ZGNX
64
DELISTED
Zogenix, Inc.
ZGNX
| $420K | 0.15% |
29,000
-38,000
| -57% | -$550K |
|
65
AbbVie
ABBV
$376B
| – | – |
0
| – | – |
|
66
Acadia Pharmaceuticals
ACAD
$4.3B
| – | – |
-65,200
| Closed | -$2.24M |
|
67
Albemarle
ALB
$9.33B
| – | – |
-22,000
| Closed | -$2.32M |
|
68
Bausch Health
BHC
$2.65B
| – | – |
0
| – | – |
|
69
BioMarin Pharmaceuticals
BMRN
$10.9B
| – | – |
0
| – | – |
|
|
BPMC
70
DELISTED
Blueprint Medicines
BPMC
| – | – |
-24,000
| Closed | -$960K |
|
71
VanEck Gold Miners ETF
GDX
$19.3B
| – | – |
-120,000
| Closed | -$2.74M |
|
|
72
Incyte
INCY
$16.8B
| – | – |
-36,000
| Closed | -$4.81M |
|
|
73
Nexstar Media Group
NXST
$6.25B
| – | – |
-41,500
| Closed | -$2.91M |
|
74
Pacira BioSciences
PCRX
$1.19B
| – | – |
-31,000
| Closed | -$1.41M |
|
75
PTC
PTC
$25.5B
| – | – |
-48,000
| Closed | -$2.52M |
|